Hideki Ohdan

Last Updated :2019/04/09

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), ., Professor
Web Site
E-mail
hohdanhiroshima-u.ac.jp
Other Contact Details
"1-2-3 KASUMI, MINAMI-KU, HIROSHIMA 734-8551", Japan
TEL : (+81)82-257-5220 FAX : (+81)82-257-5224

Basic Information

Major Professional Backgrounds

  • 2003/04/01, 2003/09/30, Hiroshima University, Hospital, Research Associate
  • 2003/10/01, 2004/03/31, Hiroshima University, Hospital, Research Associate
  • 2004/04/01, 2007/03/31, Hiroshima University, Hospital, Research Associate
  • 2007/04/01, 2008/03/31, Hiroshima University, Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Associate Professor
  • 2008/04/01, Hiroshima University, Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Professor
  • 2012/04/01, Hiroshima University, Department of Gastroenterological and Transplant Surgery, Applied Life Sciences, Professor

Educational Backgrounds

  • Hiroshima University, Faculty of Medicine, Japan, 1982/04, 1988/03
  • Hiroshima University, Graduate School, Division of Medical Sciences, Programs for Surgery, Japan, 1993/04, 1997/03

Academic Degrees

  • Ph.D. , M.D., Hiroshima University

Educational Activity

  • School of Medicine:Program of Medicine, Graduate School of Biomedical & Health Sciences:Biomedical Sciences Major

In Charge of Primary Major Programs

  • Dentistry
  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Research Keywords

  • gastroenterological Surgery
  • organ transplantation
  • immunology

Affiliated Academic Societies

  • Japanese Surgical Society
  • the Japan Soceity for Transplantation
  • The Japanese Society of Gastroenterological Surgery
  • Japanese Liver Transplantation Soceity
  • Japanese Society of Hepato-Biliary-Pancreatic Surgery
  • The Japan Society of Hepatology
  • The Japan Society for Organ Preservation and Biology
  • Japanese Soceity for Clinical Renal Transplantation
  • The Japanese Soceity of Gastroenterology
  • Japan Organ Transplant Network
  • Hiroshima Donor Bank
  • Japan Soceity of Computer Aided Surgery
  • The Transplantation Society

Educational Activity

Course in Charge

  1. 2019, Undergraduate Education, Intensive, Clinical diagnosis and treatment I
  2. 2019, Undergraduate Education, Intensive, Practice for medical research
  3. 2019, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  4. 2019, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  5. 2019, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  6. 2019, Graduate Education (Master's Program) , First Semester, Special Course of Biomedical & Health Sciences
  7. 2019, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  8. 2019, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  9. 2019, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  10. 2019, Graduate Education (Master's Program) , Second Semester, Science for Healthy Life
  11. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  12. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  13. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  14. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Lecture on Creation and Development of Biomedical Sciences
  15. 2019, Graduate Education (Master's Program) , Second Semester, General clinical medicine and dentistry
  16. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Gastroenterological and Transplant Surgery
  17. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Gastroenterological and Transplant Surgery
  18. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced research on Gastroenterological and Transplant Surgery
  19. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Gastroenterological and Transplant Surgery
  20. 2019, Graduate Education (Master's Program) , Second Semester, General Clinical Medicine and Dentistry
  21. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  22. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  23. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Gastroenterological and Transplant Surgery
  24. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Gastroenterological and Transplant Surgery
  25. 2019, Graduate Education (Master's Program) , 1Term, Biomedical Sciences
  26. 2019, Graduate Education (Doctoral Program) , 3Term, Methodology of Education for Creation and Development of Biomedical Sciences

Research Activities

Academic Papers

  1. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy, Transplantation, 82(12), 1712-1719, 20061201
  2. Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice, JOURNAL OF CLINICAL INVESTIGATION, 119(11), 3226-3235, NOV 2009
  3. Reg IV Is a Direct Target of Intestinal Transcriptional Factor CDX2 in Gastric Cancer, PLOS ONE, 7(11), NOV 2 2012
  4. The Importance of Stressing the Use of Laparoscopic Instruments in the Initial Training for Laparoscopic Surgery Using Box Trainers: A Randomized Control Study, JOURNAL OF SURGICAL RESEARCH, 174(1), 90-97, MAY 2012
  5. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 10, FEB 20 2012
  6. A huge metastatic liver tumor from leiomyosarcoma of the inferior vena cava: report of a case, SURGERY TODAY, 42(5), 505-508, MAY 2012
  7. Achievement of Sustained Viral Response after Switching Treatment from Pegylated Interferon alpha-2b to alpha-2a and Ribavirin in Patients with Recurrence of Hepatitis C Virus Genotype 1 Infection after Liver Transplantation: A Case Report, INTERVIROLOGY, 55(4), 306-310, 2012
  8. Single-port laparoscopic colectomy versus conventional laparoscopic colectomy for colon cancer: a comparison of surgical results, WORLD JOURNAL OF SURGICAL ONCOLOGY, 10, APR 24 2012
  9. Approaching time is important for assessment of endoscopic surgical skills, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 21(3), 142-149, MAY 2012
  10. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, MAY 27 2012
  11. Renal Vein Extension Using an Autologous Renal Vein in a Living Donor With Double Inferior Vena Cava: A Case Report, TRANSPLANTATION PROCEEDINGS, 44(5), 1446-1449, JUN 2012
  12. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators, NATURE GENETICS, 44(7), 760-U182, JUL 2012
  13. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells, BREAST CANCER RESEARCH AND TREATMENT, 134(1), 139-155, JUL 2012
  14. Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse, HEPATOLOGY, 56(2), 555-566, AUG 2012
  15. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer, CANCER SCIENCE, 103(9), 1744-1750, SEP 2012
  16. Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy, ANNALS OF SURGICAL ONCOLOGY, 19(9), 2888-2896, SEP 2012
  17. Primary lung cancer presenting with metastasis to the colon: a case report, WORLD JOURNAL OF SURGICAL ONCOLOGY, 10, JUN 28 2012
  18. Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation With Hepatocellular Carcinoma, CELL TRANSPLANTATION, 21(7), 1397-1406, 2012
  19. Preventive effect of G-CSF on acute lung injury via alveolar macrophage regulation, JOURNAL OF SURGICAL RESEARCH, 178(1), 378-384, NOV 2012
  20. The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 31(2), 299-306, FEB 2013
  21. Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I nonsmall cell lung cancer, CANCER, 119(4), 792-798, FEB 15 2013
  22. Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: Tumor-by-tumor analysis in explant livers, JOURNAL OF MAGNETIC RESONANCE IMAGING, 37(3), 684-691, MAR 2013
  23. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, MAR 2013
  24. Expression of Recipient CD47 on Rat Insulinoma Cell Xenografts Prevents Macrophage-Mediated Rejection through SIRP alpha Inhibitory Signaling in Mice, PLOS ONE, 8(3), MAR 5 2013
  25. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery, SURGERY, 153(3), 344-356, MAR 2013
  26. Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: report of a case, SURGERY TODAY, 43(4), 418-423, APR 2013
  27. Controlling the bleeding of jejunal varices formed at the site of choledochojejunostomy: report of 2 cases and a review of the literature, SURGERY TODAY, 43(5), 550-555, MAY 2013
  28. Evaluating the correlation between the HUESAD and OSATS scores: Concurrent validity study, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 22(3), 144-149, 2013
  29. Virtual reality training followed by box training improves the laparoscopic skills of novice surgeons, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 22(3), 150-156, 2013
  30. Reliability and validity of a new living liver donor quality of life scale, SURGERY TODAY, 43(7), 732-740, JUL 2013
  31. Comparative Analysis of T-Cell Depletion Method for Clinical Immunotherapy-Anti-Hepatitis C Effects of Natural Killer Cells Via Interferon-gamma Production, TRANSPLANTATION PROCEEDINGS, 45(5), 2045-2050, JUN 2013
  32. Adoptive Transfer of Allogeneic Liver Sinusoidal Endothelial Cells Specifically Inhibits T-Cell Responses to Cognate Stimuli, CELL TRANSPLANTATION, 22(9), 1695-1708, 2013
  33. Prevention of recurrence after curative treatment for hepatocellular carcinoma, SURGERY TODAY, 43(12), 1347-1354, DEC 2013
  34. HLA-DR8 subtyping by polymerase chain reaction (PCR)-DNA conformation polymorphism(DCP) analysis; a simple and practical genotyping method., Hiroshima J. Med. Sci., 45(3), 85-92, 19960901
  35. Liver preservation and liver ischemia-reperfusion injury., Transplantation Now, 12(6), 582-587, 19991101
  36. Diagnostic value of non-invasive near-infrared spectroscopy to assess liver viability of brain dead donor., Transplantation Proceedings, 31, 2922-2923, 19990401
  37. Selection of treatment-hepatectomy-, 78(7), 1225-1228, 20010401
  38. Estimation of Graft Blood Flow in Rat Lung Transplantation Using Near-Infrared Spectroscopy, Transplantation Proceedings, 32, 2437-2438, 20000401
  39. Rearterialization of Hepatic Xenografts in the Combination of Hamster-to-Rat, Transplantation Proceedings, 32, 1127-1128, 20000401
  40. Efficacy of HSP72 induction in rat liver by orally administered geranylgeranylacetone, Transplant International, 13(SUPPL.1), 278-281, 20000401
  41. Stable Technique for Reconstruction of Hepatic Artery in Hamster-to-Rat Liver Transplantation, Transplantation Proceedings, 32, 2341-2342, 20000401
  42. Prevention of Warm Ischemic Injury in Rat Liver Transplantation by Geranylgeranylacetone, Transplantation Proceedings, 32, 1615-1616, 20000401
  43. Nondestructive and real-time evaluation of liver viability in brain dead donor for liver transplantation using near-infrared spectroscopy, The Institute of Statistical Research, 13(SUPPL.1), 272-277, 20000401
  44. Simultaneous estimation of pulmonary edema and tissue oxygenation by near-infrared spectroscopy, Transplantation Proceedings, 31, 178-179, 19990401
  45. Novel assessment of acute lung injury by in vivo near-infrared spectroscopy, Am J Resp Crit Care Med, 160(1), 317-323, 19990401
  46. Oral Administration of Geranylgeranylacetone Protects Rat Livers from Warm Ischemic Injury, Transplantation Proceedings, 31, 2918-2919, 19990401
  47. Effect of geranylgeranylacetone against rat liverwarm ischemic repertusion injory, Organ Biology, 6(4), 73-78, 19990401
  48. Augmentation of microchimerism with donor bone marrow infusion in Hamster-to-rat heart xenograft recipient, Transplantation Proceedings, 31, 694-695, 19990401
  49. Novel use of near-infrared spectroscopy to determine cytochrome oxidase a,a3 reactivity of lung impeded by warm ischemia, Transplantation Proceedings, 30, 3361-3363, 19980401
  50. Estimation of lung water content by near-infrared spectroscopy after warm ischemia, Transplantation Proceedings, 30, 3582-3583, 19980401
  51. Expression of bcl-2 homologue mRNAs in rat liver allograft: rejection-induced cell apoptosis is associated with upregulation of bax and bcl-xs expression, Transplant International, 11(SUPPL.1), 284-288, 19980401
  52. Analysis of Bcl-X in Rat Liver Allograft: Rejection-Induced Apoptosis Is Associated with Up-Regulation of Bcl-xs Expression, Transplantation Proceedings, 30, 2941, 19980401
  53. Effects of Deoxyspergualin(DSG) Administered in the Chronic Phase Following Kidney Transplantation, Transplantation Proceedings, 30, 3682-3683, 19980401
  54. Malignant mesothelioma originating in the hepatic falciform ligament : Report of a case, Surgery Today, 28, 929-931, 19980401
  55. Development of Xenogeneic Microchimerism Correlated with Graft Outcome in Hamster-to-Rat Heart Xenotransplantation, Transplantation Proceedings, 30, 2484-2485, 19980401
  56. Dynamic changes in xenogeneic microchimerism after hamster-to-rat lung and heart xenotransplantation, Transplantation Proceedings, 30, 3867-3868, 19980401
  57. Effect of Simultaneous Infusion of Donor Bone Marrow on Hamster-to-Rat Heart Xenotransplantation, Transplantation Proceedings, 30, 3869-3870, 19980401
  58. Prolongation of concordant xenograft survival by treatment with FTY720, Transplantation Proceedings, 30, 4163-4165, 19980401
  59. Relationship of Xenogeneic Microchimerism to Graft Outcome in Hamster-to-Rat Lung Xenotransplantation, J. Heart Lung Transplant., 17, 233-240, 19980401
  60. Role of the bcl-2/bax pathway in hepatocyte apoptosis during acute rejection after rat liver transplantation, Transplant International, 11, 179-184, 19980401
  61. Analysis of apoptosis-associated genes: Fas ligand, Bcl-2 and Bax in the rat liver allograft, Transplantation Proceedings, 30, 22-24, 19980401
  62. Preventive efficacy of 15-Deoxyspergualin against progression of apoptotic cell death in acute rejection after rat liver transplantation, Transplantation Proceedings, 30, 4104-4105, 19980401
  63. Expression of Bcl-2/Bax in RNA in grafted liver during acute rejection after rat liver transplantation, Transplantation Proceedings, 30, 2950-2951, 19980401
  64. Modulation of Kupffer cells affects the metabolism of protease inhibitor administered in cold-preserved liver transplantation, Transplantation Proceedings, 29, 3358-3359, 19970401
  65. Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation, Transplantation Proceedings, 29(1-2), 925-927, 19970201
  66. Frequent occurrence of hepatocytic apoptosis in acute rejection of the grafted rat liver, Pathology International, 47(8), 518-524, 19970401
  67. Near-infrared spectroscopic method for assessing the tissue oxygenation state of living lung, Am J Respir Crit Care Med, 156(5), 1656-1661, 19970401
  68. Analysis of xenogeneic microchimerism in hamster-to-rat lung xenotransplantation, Transplantation Proceedings, 29, 3505-3507, 19970401
  69. Synergistic effects of nafamostat mesilate rinse and Kupffer cell blockade for rat 1iver preservation, Transplant International, 9, 447-451, 19960401
  70. Optimal pH of UW solution and rinse solution for liver preservation, Transplantation Proceedings, 28, 1891-1892, 19960401
  71. Organ Preservation and evaluation of viability, Organ Biology, 7(3), 43-52, 20000401
  72. High dose of Geranylgeranylacetone accumulate HSP72 mRNA in rat liver, Transplantation Proceedings, 33, 978, 20010401
  73. ROCK inhibitor Y-27632 prevents primary graft non-function caused by warm ischemia/reperfusion in rat liver transplantation, The Institute of Statistical Research, 15(2), 623-629, 20020401
  74. Beneficial effects of a Rho-associated coiled-coli forming protein serine/threonine kinase inhibitor, Y-27632, on survival of recipients in rat liver transplantation following warm ischemia, Transplantation Proceedings, 34, 2643-2644, 20020401
  75. The Role of Mouse Stroma in Rat Haematopoiesis in Xenogeneic Rat/Mouse Bone Marrow Transplantation Chimeras, Transplantation Proceedings, 34, 2759, 20020401
  76. Gasless laparoscopic hepatic resection for cirrhotic patients with solid liver tumors, 12(5), 325-330, 20020401
  77. Enzyme-linked immunospot assay for detecting cells secreting antibodies against human blood group A epitopes, Transplantation Proceedings, 35, 555-556, 20030401
  78. ROCK inhibitor, Y-27632, Inhibits Anoxia-Reoxygenation-Induced Contraction of Hepatic Stellate Cells, Transplantation Proceedings, 35, 111-113, 20030401
  79. Limited Engraftment Capacity of Bone Marrow-Derived Mesenchymal Cells in Xenogeneic Bone Marrow Transplantation, Transplantation Proceedings, 35, 504-505, 20030201
  80. Multiparameter Flow Cytometric Mixed Lymphocyte Reaction Assay Using Fluorescent Cytoplasmic Dye for Assessing Phenotypic Property of T Cells Responding to Allogeneic Stimulation, Transplantation Proceedings, 35, 557-558, 20030401
  81. Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor., Transplantation, 75(5), 579-586, 20030301
  82. Novel Method Using Near-Infrared Spectroscopy to Assess Intrahepatic Anastomosis Between Hepatic Veins of Right Lobe Graft in Living-Donor Liver Transplantation, Transplantation Proceedings, 34, 2781, 20020401
  83. NOD/SCID mice engrafted with human peripheral blood group A carbohydrate determinant, Transplant Immunology, 12, 9-18, 20030401
  84. Construction of ectopic xenogeneic bone marrow structure associated with persistent multi-lineage mixed chimerism by engraftment of rat bone marrow plugs into mouse kidney capsules, Xenotransplantation, 10(3), 259-266, 20030401
  85. Resection of Hepatocellular Carcinoma in a Patient with Congenital Anrmaly of the Portal System, Digestive Surgery, 20, 163-165, 20030401
  86. Liver NK Cells Expressing TRAIL Are Toxic Against Self Hepatocytes in Mice, Hepatology, 33(5), 1322-1331, 20040501
  87. Studies on eleven Kidney transplants from non-heart-beating donors, Hiroshima J. Med. Sci., 53(1), 7-11, 20040301
  88. Allochronic overlapping malignancies after renal transplantation in a patient with p53 gene mutation: Report of a case, Surg Today, 34(5), 473-476, 20040501
  89. Involvement of tumor necrosis factor-alpha recptor 1 and tumor necrosis factor-related apoptosisi-inducing ligand-(TRAIL) recptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation, Transplant International, 17(10), 626-633, 20041101
  90. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation., Immunological Investigations, 33(3), 309-324, 20040801
  91. Differential diagnosisi between graft-versus-host disease and hemophagocytic syndrome after living- related liver transplantation by mixed lymphocyte reaction assay, Journal of Investigative Surgery, 17(4), 197-202, 20040801
  92. Near-infrared-spectroscopic analysis of hepatic hemodynamics and oxygen metabolism after extensive hepatectomy, Medical Science Monitoring, 10(10), 356-361, 20041001
  93. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis, The American Journal of Surgery, 189, 167-172, 20050201
  94. Antibody-and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells, Xenotransplantation, 12(3), 181-188, 20050501
  95. Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation, Transplantation Proceedings, 37(4), 1808-1811, 20050501
  96. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation, The American Journal of Surgery, 190(1), 65-68, 20050401
  97. Low incidence of acute rejection after living-donor liver transplantation:immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidy1 ester labeling technique, Transplantation, 79(9), 1262-1267, 20050501
  98. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes, Transpl. Int., 18(2), 237-245, 20050201
  99. Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as child-pugh class B, World J.Surg. 29(6):734-8., 29(6), 734-738, 20050601
  100. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma, Hepato-Gastroenterology, 52(64), 1163-1167, 20050701
  101. Studies on post-transplant dyslipidemia in kidney transplant patients, Hiroshima J. Med. Sci., 54(2), 39-45, 20050601
  102. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans., Hepatology, 43(2), 362-372., 20060201
  103. Induction of endotoxin tolerance inhibits alloimmune responses., Transpl Immunol., 16(3-4), 158-165, 20060701
  104. Safety of donor right hepatectomy for adult-to-adult living donor liver transplantation., The Institute of Statistical Research, 19(3), 177-183, 20060301
  105. Radiofrequency-assited Partial splenectomy with a new and simple divice, The American Journal of Surgery, 192, 252-254, 20060801
  106. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity., J. Immunol., 177(6), 3615-3624, 20060901
  107. Near-infrared spectroscopic analysis of hemodynamics and mitochondrial redox in right lobe grafts in living-donor liver transplantation, Am J Transplant., 6(4), 797-805, 20060401
  108. Clinicopathologic features of poorly differentiated hepatocellular carcinoma., J. Surg. Oncol, 95(4), 311-316, 20070301
  109. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10years after curative hepatectomy, World J. Surg., 31(2), 345-352., 20070201
  110. Evidence of Immune Tolerance to Blood Group Antigens in a Case of ABO-Incompatible Pediatric Liver Transplantation, Am J Transplant, 7(9), 2190-2194, 20070901
  111. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, Transpl Int, 20(11), 970-973, 20071101
  112. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation, Blood, 110(13), 4546-4575, 20071201
  113. Repeat hepatectomy for recurrent hepatocellular carcinoma, Surgery, 141(5), 589-597, 20070501
  114. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients, Transpl Int, 20(7), 632-635, 20070401
  115. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation, J Gastroenterol Hepatol, 22(6), 959-960, 20070601
  116. Biliary Complications after Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation : Causes and Treatment, World Journal of Surgery, 31(11), 2222-2229, 20071101
  117. Case report: Splenic artery steal syndrome in living-donor liver transplantation, Transplant Proc, 39(10), 3519-3522, 20071201
  118. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats., Transplantation, 76(5), 761-765, 20030401
  119. Liver sinusoidal endothelial cells have a capacity for inducing nonresponsiveness of T cells across major histocompatibility complex barriers, The Institute of Statistical Research, 18(2), 206-214, 20050201
  120. Evidence of Immune Tolerance to Blood Group Antigens in a Case of ABO-Incompatible Pediatric Liver Transplantation, American Journal of Transplantation, 7(9), 2190-2194, 20070901
  121. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, The Institute of Statistical Research, 20(11), 970-973, 20071101
  122. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment., World Journal of Surgery, 31(11), 2222-2229, 20071101
  123. Repeat hepatectomy for recurrent hepatocellular carcinoma., Surgery, 141(5), 589-597, 20070501
  124. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages., Proc Natl Acad Sci USA, 104(12), 5062-5066, 20070301
  125. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients., The Institute of Statistical Research, 20(7), 632-635, 20070701
  126. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?, J Gastroenterol Hepatol, 22(6), 959-960, 20070201
  127. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation., Blood, 110(13), 4567-4575, 20071201
  128. Splenic artery steal syndrome in living donor liver transplantation: a case report., Transplantation Proceedings, 39(10), 3519-3522, 20071201
  129. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment., World J Surg., 31(11), 2222-9., 20071101
  130. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment., World J Surg, 31(11), 2222-9, 20071101
  131. Quantification of T-Cell Proliferation for Individualizing Immunosuppressive Therapy for Transplantation Patients, Clin Pharmacol Ther, 87(1), 23-26, 20100101
  132. Idiopathic granulomatous gastritis resembling a gastrointestinal stromal tumor., Case Rep Gastroenterol, 6(2), 502-9, 20120701
  133. Safety and Efficacy of Laparoscopy-Assisted Gastrectomy after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Retrospective Report., Journal of Cancer Therapy, 4(1), 54-60, 20130401
  134. IL28B SNP of donors and recipients can predict virological response to PEGIFN/RBV therapy in patients with recurrent hepatitis C after living donor liver transplantation., J Gastroenterol Hepatol., 20120901
  135. Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report., J Med Case Rep, 13, 154, 20120601
  136. Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient., World J Hepatol., 4, 191-195, 20120601
  137. Idiopathic granulomatous gastritis resembling a gastrointestinal stromal tumor., Case Rep Gastroenterol., 6, 502-509, 20120501
  138. Impact of laparoscopic experience on the proficiency gain of urological surgeons in robot-assisted surgery., J Endourol., 20120801
  139. Submucosal invasive micropapillary carcinoma of the colon with massive lymph node metastases: a case report, Case Rep Oncol, 5, 608-615, 20120901
  140. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients., Breast Cancer., 20130101
  141. Safety and Efficacy of Laparoscopy-Assisted Gastrectomy after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Retrospective Report, journal of cancer therapy, 4, 54-56, 20130101
  142. Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report, BMC Gastroenterol, 12, 98, 20120701
  143. Triple-Tube-Ostomy: A Novel Technique for the Surgical Treatment of Iatrogenic Duodenal Perforation, Case Reports in Gastroenterology, 5(3), 672-679, 20111201
  144. Thoracoscopic-assisted repair of a Bochdalek hernia in an adult: a case report, J Med Case Reports, 4(1), 366, 20101101
  145. Preliminary trial of adjuvant surgery for advanced gastric cancer, Oncol Lett, 1, 743-747, 20100501
  146. Rearterialization of hepatic xenografts in the combination of hamster-to-rat, TRANSPLANTATION PROCEEDINGS, 32(5), 1127-1128, AUG 2000
  147. Prevention of warm ischemic injury in rat liver transplantation by geranylgeranylacetone, TRANSPLANTATION PROCEEDINGS, 32(7), 1615-1616, NOV 2000
  148. Stable technique for reconstruction of hepatic artery in hamster-to-rat liver transplantation, TRANSPLANTATION PROCEEDINGS, 32(7), 2341-2342, NOV 2000
  149. Estimation of graft blood flow in rat lung transplantation using near-infrared spectroscopy, TRANSPLANTATION PROCEEDINGS, 32(7), 2437-2438, NOV 2000
  150. High dose of geranylgeranylacetone accumulate HSP72 mRNA in rat liver, TRANSPLANTATION PROCEEDINGS, 33(1-2), 978-978, FEB-MAR 2001
  151. Geranylgeranylacetone, a heat shock protein inducer, prevents primary graft nonfunction in rat liver transplantation, TRANSPLANTATION, 72(2), 184-189, JUL 27 2001
  152. ROCK inhibitor, Y-27632, inhibits anoxia-reoxygenation-induced contraction of hepatic stellate cells, TRANSPLANTATION PROCEEDINGS, 35(1), 111-113, FEB 2003
  153. Gasless laparoscopic hepatic resection for cirrhotic patients with solid liver tumors, SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 12(5), 325-330, OCT 2002
  154. Beneficial effects of a Rho-associated coiled-coli forming protein serine/threonine kinase inhibitor, Y-27632, on survival of recipients in rat liver transplantation following warm ischemia, TRANSPLANTATION PROCEEDINGS, 34(7), 2643-2644, NOV 2002
  155. The role of mouse stroma in rat haematopoiesis in xenogeneic rat/mouse bone marrow transplantation chimeras, TRANSPLANTATION PROCEEDINGS, 34(7), 2759-2759, NOV 2002
  156. Novel method using near-infrared spectroscopy to assess intrahepatic anastomosis between hepatic veins of right lobe graft in living-donor liver transplantation, TRANSPLANTATION PROCEEDINGS, 34(7), 2781-2781, NOV 2002
  157. ROCK inhibitor Y-27632 prevents primary graft non-function caused by warm ischemia/reperfusion in rat liver transplantation, TRANSPLANT INTERNATIONAL, 15(12), 623-629, DEC 2002
  158. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats, TRANSPLANTATION, 76(5), 761-765, SEP 15 2003
  159. Intraoperative near-infrared spectroscopy for evaluating hepatic venous outflow in living-donor right lobe liver., TRANSPLANTATION, 76(5), 791-797, SEP 15 2003
  160. Limited engraftment capacity of bone marrow-derived mesenchymal cells in xenogeneic bone marrow transplantation, TRANSPLANTATION PROCEEDINGS, 35(1), 504-505, FEB 2003
  161. Enzyme-linked immunospot assay for detecting cells secreting antibodies against human blood group A epitopes, TRANSPLANTATION PROCEEDINGS, 35(1), 555-556, FEB 2003
  162. Multiparameter flow cytometric mixed lymphocyte reaction assay using fluorescent cytoplasmic dye for assessing phenotypic property of T cells responding to allogeneic stimulation, TRANSPLANTATION PROCEEDINGS, 35(1), 557-558, FEB 2003
  163. B cell tolerance to xenoantigens, XENOTRANSPLANTATION, 10(2), 98-106, MAR 2003
  164. Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor., TRANSPLANTATION, 75(5), 579-586, MAR 15 2003
  165. Resection of hepatocellular carcinoma in a patient with congenital anomaly of the portal system, DIGESTIVE SURGERY, 20(2), 163-165, 2003
  166. Construction of ectopic xenogeneic bone marrow structure associated with persistent multi-lineage mixed chimerism by engraftment of rat bone marrow plugs into mouse kidney capsules, XENOTRANSPLANTATION, 10(3), 259-266, MAY 2003
  167. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant, TRANSPLANT IMMUNOLOGY, 12(1), 9-18, OCT-NOV 2003
  168. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice, HEPATOLOGY, 39(5), 1321-1331, MAY 2004
  169. Allochronic overlapping malignancies after renal transplantation in a patient with p53 gene mutation: Report of a case, SURGERY TODAY, 34(5), 473-476, MAY 2004
  170. Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay, JOURNAL OF INVESTIGATIVE SURGERY, 17(4), 197-202, JUL-AUG 2004
  171. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation, IMMUNOLOGICAL INVESTIGATIONS, 33(3), 309-324, 2004
  172. Near-infrared spectroscopic analysis of hepatic hemodynamics and oxygen metabolism after extensive hepatectomy, MEDICAL SCIENCE MONITOR, 10(10), BR356-BR361, OCT 2004
  173. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation, TRANSPLANT INTERNATIONAL, 17(10), 626-633, OCT 2004
  174. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis, AMERICAN JOURNAL OF SURGERY, 189(2), 167-172, FEB 2005
  175. Liver sinusoidal endothelial cells have a capacity for inducing nonresponsiveness of T cells across major histocompatibility complex barriers, TRANSPLANT INTERNATIONAL, 18(2), 206-214, FEB 2005
  176. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes, TRANSPLANT INTERNATIONAL, 18(2), 237-245, FEB 2005
  177. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells, XENOTRANSPLANTATION, 12(3), 181-188, MAY 2005
  178. Low incidence of acute rejection after living-donor liver transplantation: Immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique, TRANSPLANTATION, 79(9), 1262-1267, MAY 15 2005
  179. Calcineurin inhibitors block B-1 cell differentiation: The relevance to immunosuppressive treatment in ABO-incompatible transplantation, TRANSPLANTATION PROCEEDINGS, 37(4), 1808-1811, MAY 2005
  180. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma, HEPATO-GASTROENTEROLOGY, 52(64), 1163-1167, JUL-AUG 2005
  181. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice, JOURNAL OF IMMUNOLOGY, 175(1), 139-146, JUL 1 2005
  182. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation, AMERICAN JOURNAL OF SURGERY, 190(1), 65-68, JUL 2005
  183. Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B, WORLD JOURNAL OF SURGERY, 29(6), 734-738, JUN 2005
  184. B cell tolerance and xenotransplantation, CURRENT OPINION IN ORGAN TRANSPLANTATION, 10(3), 252-258, SEP 2005
  185. Safety of donor right hepatectomy for adult-to-adult living donor liver transplantation, TRANSPLANT INTERNATIONAL, 19(3), 177-183, MAR 2006
  186. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans, HEPATOLOGY, 43(2), 362-372, FEB 2006
  187. Near-infrared spectroscopic analysis of hemodynamics and mitochondrial redox in right lobe grafts in living-donor liver transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 6(4), 797-805, APR 2006
  188. Radiofrequency-assisted partial splenectomy with a new and simple device, AMERICAN JOURNAL OF SURGERY, 192(2), 252-254, AUG 2006
  189. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity, JOURNAL OF IMMUNOLOGY, 177(6), 3615-3624, SEP 15 2006
  190. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy, TRANSPLANTATION, 82(12), 1712-1719, DEC 27 2006
  191. Induction of endotoxin tolerance inhibits alloimmune responses, TRANSPLANT IMMUNOLOGY, 16(3-4), 158-165, NOV 2006
  192. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy, WORLD JOURNAL OF SURGERY, 31(2), 345-352, FEB 2007
  193. Clinicopathologic features of poorly differentiated hepatocellular carcinoma, JOURNAL OF SURGICAL ONCOLOGY, 95(4), 311-316, MAR 15 2007
  194. Role for CD47-SIRP alpha signaling in xenograft rejection by macrophages, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 104(12), 5062-5066, MAR 20 2007
  195. Repeat hepatectomy for recurrent hepatocellular carcinoma, SURGERY, 141(5), 589-597, MAY 2007
  196. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients, TRANSPLANT INTERNATIONAL, 20(7), 632-635, JUL 2007
  197. alpha 1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: Where do we go from here?, TRANSPLANTATION, 84(1), 1-7, JUL 15 2007
  198. Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 7(9), 2190-2194, SEP 2007
  199. Splenic artery steal syndrome in living donor liver transplantation: A case report, TRANSPLANTATION PROCEEDINGS, 39(10), 3519-3522, DEC 2007
  200. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, TRANSPLANT INTERNATIONAL, 20(11), 970-973, NOV 2007
  201. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: Causes and treatment, WORLD JOURNAL OF SURGERY, 31(11), 2222-2229, NOV 2007
  202. Reconstruction of the middle hepatic vein tributaries draining segments V and VIII of a right liver graft by using the recipient's own middle hepatic vein and vascular closure staples, SURGERY TODAY, 38(3), 289-291, MAR 2008
  203. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation, BLOOD, 110(13), 4567-4575, DEC 15 2007
  204. Current status of liver transplantation across ABO blood-type barrier, JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 15(2), 131-138, MAR 2008
  205. Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia, JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 15(2), 200-203, MAR 2008
  206. Hepatic venous outflow obstruction after right lateral sector living-donor liver transplantation, treated by insertion of an expandable metallic stent, JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 15(2), 228-231, MAR 2008
  207. Role of invariant natural killer T cells in liver sinusoidal endothelian cell-induced immunosuppression among T cells with indirect allospecificty, TRANSPLANTATION, 85(7), 1060-1064, APR 15 2008
  208. Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 43(5), 369-377, 2008
  209. Engraftment of human hepatocytes in the livers of rats bearing bone marrow reconstructed with immunodeficient mouse bone marrow cells, XENOTRANSPLANTATION, 15(4), 235-245, JUL-AUG 2008
  210. Laminin gamma 2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells, GASTROENTEROLOGY, 137(1), 242-252, JUL 2009
  211. Prophylaxis against Recurrence of HBV Hepatitis after Living-donor Liver Transplantation, HEPATO-GASTROENTEROLOGY, 55(86-87), 1746-1749, SEP-OCT 2008
  212. Reconstruction of the Middle Hepatic Vein Tributary with Resection of the Middle Hepatic Vein Trunk: Report of a Case, HEPATO-GASTROENTEROLOGY, 55(86-87), 1773-1775, SEP-OCT 2008
  213. Retroperitoneal abscess complicated with necrotizing fasciitis of the thigh in a patient with sigmoid colon cancer, WORLD JOURNAL OF SURGICAL ONCOLOGY, 7, OCT 7 2009
  214. Using Recipient's Middle Hepatic Vein for Drainage of the Right Paramedian Sector in Right Liver Graft, TRANSPLANTATION, 86(11), 1565-1571, DEC 15 2008
  215. Significant Correlation Between Spleen Volume and Thrombocytopenia in Liver Transplant Patients: A Concept for Predicting Persistent Thrombocytopenia, LIVER TRANSPLANTATION, 15(2), 208-215, FEB 2009
  216. Abscess in the inguinal hernial sac after peritonitis surgery: A case report, WORLD JOURNAL OF GASTROENTEROLOGY, 15(8), 1007-1009, FEB 28 2009
  217. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia, HEPATOLOGY RESEARCH, 39(5), 520-524, MAY 2009
  218. Hepatectomy for Hepatocellular Carcinoma in Elderly Patients Aged 75 Years or More, JOURNAL OF GASTROINTESTINAL SURGERY, 13(4), 695-701, APR 2009
  219. Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness, TRANSPLANT INTERNATIONAL, 22(8), 805-813, AUG 2009
  220. Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14(5), 465-467, OCT 2009
  221. Suppression of Hepatocellular Carcinoma Recurrence After Rat Liver Transplantation by FTY720, a Sphingosine-1-Phosphate Analog, TRANSPLANTATION, 88(8), 980-986, OCT 27 2009
  222. Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 8, MAY 19 2010
  223. Hybrid Hand-Assisted Colectomy for Transverse Colon Cancer: A Useful Technique for Non-Expert Laparoscopic Surgeons, WORLD JOURNAL OF SURGERY, 33(12), 2683-2687, DEC 2009
  224. Remission of Splenic Volume in the Recipient During the Course of Adult-to-Adult Living Donor Liver Transplantation: Evaluation Using Multislice Computed Tomography and Semiautomatic Software, TRANSPLANTATION PROCEEDINGS, 41(9), 3772-3774, NOV 2009
  225. Successful Living Donor Left Liver Transplantation by Using Liver Graft With Multiple Large Cysts: A Case Report, TRANSPLANTATION PROCEEDINGS, 41(9), 3923-3926, NOV 2009
  226. Scientific assessment of endoscopic surgical skills, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 19(1), 30-34, FEB 2010
  227. Immunological Property of Antibodies against N-Glycolylneuraminic Acid Epitopes in Cytidine Monophospho-N-Acetylneuraminic Acid Hydroxylase-Deficient Mice, JOURNAL OF IMMUNOLOGY, 184(6), 3269-3275, MAR 15 2010
  228. Comparison of immunohistochemistry assays and real-time reverse transcription-polymerase chain reaction for analyzing hormone receptor status in human breast carcinoma, PATHOLOGY INTERNATIONAL, 60(4), 305-315, APR 2010
  229. Gastrointestinal stromal tumors of the small intestine in pediatric populations: a case report and literature review, PEDIATRIC SURGERY INTERNATIONAL, 26(6), 649-654, JUN 2010
  230. Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes, XENOTRANSPLANTATION, 17(3), 188-196, MAY-JUN 2010
  231. Alterations in portal vein blood pH, hepatic functions, and hepatic histology in a porcine carbon dioxide pneumoperitoneum model, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 24(7), 1693-1700, JUL 2010
  232. CDX2 Regulates Multidrug Resistance 1 Gene Expression in Malignant Intestinal Epithelium, CANCER RESEARCH, 70(17), 6767-6778, SEP 1 2010
  233. Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: Analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virus, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 45(12), 1488-1496, DEC 2010
  234. Preliminary trial of adjuvant surgery for advanced gastric cancer, ONCOLOGY LETTERS, 1(4), 743-747, JUL-AUG 2010
  235. Deficiency of N-glycolylneuraminic acid and Gal alpha 1-3Gal beta 1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies, XENOTRANSPLANTATION, 17(6), 440-448, NOV-DEC 2010
  236. A New Method for Intraluminal Gastrointestinal Stromal Tumor Resection Using Laparoscopic Seromuscular Dissection Technique, DIGESTIVE SURGERY, 27(6), 461-465, 2010
  237. Possibility of Adoptive Immunotherapy With Peripheral Blood-derived CD3(-)CD56(+) and CD3(+)CD56(+) Cells for Inducing Antihepatocellular Carcinoma and Antihepatitis C Virus Activity, JOURNAL OF IMMUNOTHERAPY, 34(2), 137-146, MAR 2011
  238. Splenectomy in Chronic Hepatic Disorders: Portal Vein Thrombosis and Improvement of Liver Function, DIGESTIVE SURGERY, 28(1), 9-14, 2011
  239. Therapeutic Potential of Propagated Hepatocyte Transplantation in Liver Failure, JOURNAL OF SURGICAL RESEARCH, 167(1), E29-E37, MAY 2011
  240. Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B, WORLD JOURNAL OF SURGERY, 35(4), 834-841, APR 2011
  241. Malignant peripheral nerve sheath tumor arising from the greater omentum: Case report, WORLD JOURNAL OF SURGICAL ONCOLOGY, 9, MAR 21 2011
  242. Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection, JOURNAL OF SURGICAL ONCOLOGY, 104(1), 3-9, JUL 1 2011
  243. Significance of Platelet Count in the Outcomes of Hepatectomized Patients with Hepatocellular Carcinoma Exceeding the Milan Criteria, JOURNAL OF GASTROINTESTINAL SURGERY, 15(7), 1173-1181, JUL 2011
  244. Relationship between the cAMP levels in leukocytes and the cytokine balance in patients surviving gram negative bacterial pneumonia, JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 48(2), 134-141, MAR 2 2011
  245. Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18(5), 689-699, SEP 2011
  246. Long-Term Outcome of Hepatic Artery Reconstruction during Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 43(5), 1720-1724, JUN 2011
  247. Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs), PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(28), 11542-11547, JUL 12 2011
  248. Kinetics of Cellular and Humoral Immunity in a Successful Case of Positive Crossmatch Kidney Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 43(6), 2411-2414, JUL-AUG 2011
  249. Impact of Adjuvant Immunotherapy Using Liver Allograft-Derived Lymphocytes on Bacteremia in Living-Donor Liver Transplantation, TRANSPLANTATION, 92(5), 575-580, SEP 2011
  250. External Validation of Two Nomograms for Predicting Patient Survival After Hepatic Resection for Metastatic Colorectal Cancer, WORLD JOURNAL OF SURGERY, 35(10), 2275-2282, OCT 2011
  251. Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer, SURGERY TODAY, 41(10), 1370-1379, OCT 2011
  252. IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma, JOURNAL OF VIRAL HEPATITIS, 18(10), E550-E560, OCT 2011
  253. Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining region, HEPATOLOGY RESEARCH, 41(11), 1126-1131, NOV 2011
  254. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver, JOURNAL OF HEPATOLOGY, 56(1), 146-152, JAN 2012
  255. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, 19(2), 418-425, FEB 2012
  256. Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, SURGERY TODAY, 42(3), 245-249, FEB 2012
  257. An Anti-Wnt5a Antibody Suppresses Metastasis of Gastric Cancer Cells In Vivo by Inhibiting Receptor-Mediated Endocytosis, MOLECULAR CANCER THERAPEUTICS, 11(2), 298-307, FEB 2012
  258. Human CD47 Expression Permits Survival of Porcine Cells in Immunodeficient Mice That Express SIRP alpha Capable of Binding to Human CD47, CELL TRANSPLANTATION, 20(11-12), 1915-1920, 2011
  259. No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy, WORLD JOURNAL OF SURGERY, 36(3), 651-658, MAR 2012
  260. SINGLE-INCISION LAPAROSCOPIC COLECTOMY USING THE GELPORT SYSTEM FOR EARLY COLON CANCER, SCANDINAVIAN JOURNAL OF SURGERY, 101(1), 16-20, 2012
  261. Optimization of Immunosuppressive Therapy Based on a Multiparametric Mixed Lymphocyte Reaction Assay Reduces Infectious Complications and Mortality in Living Donor Liver Transplant Recipients, TRANSPLANTATION PROCEEDINGS, 44(2), 555-559, MAR 2012
  262. Complex Vascular Reconstruction Using Donor's Vessel Grafts in Orthotopic Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 44(2), 574-578, MAR 2012
  263. Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 27(10), 1339-1346, OCT 2012
  264. Impact of Laparoscopic Experience on the Proficiency Gain of Urologic Surgeons in Robot-Assisted Surgery, JOURNAL OF ENDOUROLOGY, 26(12), 1635-1638, DEC 2012
  265. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27(9), 1467-1472, SEP 2012
  266. Face, Content and Concurrent Validity of the Mimic (R) dV-Trainer for Robot-Assisted Endoscopic Surgery: A Prospective Study, EUROPEAN SURGICAL RESEARCH, 50(3-4), 292-300, 2013
  267. Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery, LANGENBECKS ARCHIVES OF SURGERY, 398(6), 833-839, AUG 2013
  268. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, AUG 6 2013
  269. Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group A carbohydrates, BLOOD, 122(15), 2582-2590, OCT 10 2013
  270. Surgical treatment for isolated inguinal lymph node metastasis in lower rectal adenocarcinoma patients improves outcome, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 28(12), 1675-1680, DEC 2013
  271. Effect of Left Colonic Artery Preservation on Anastomotic Leakage in Laparoscopic Anterior Resection for Middle and Low Rectal Cancer, WORLD JOURNAL OF SURGERY, 37(12), 2935-2943, DEC 2013
  272. The USP21 Short Variant (USP21SV) Lacking NES, Located Mostly in the Nucleus In Vivo, Activates Transcription by Deubiquitylating ubH2A In Vitro, PLOS ONE, 8(11), NOV 22 2013
  273. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/ gamma(c)(null) mice, CLINICAL TRANSPLANTATION, 27(6), E702-E708, NOV 2013
  274. Overexpression of Hypoxia Inducible Factor-1 Alpha is an Independent Risk Factor for Recurrence After Curative Resection of Colorectal Liver Metastases, ANNALS OF SURGICAL ONCOLOGY, 20, S527-S536, DEC 2013
  275. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(51), 20699-20704, DEC 17 2013
  276. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS, 46(3), 785-789, APR 2014
  277. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, JUN 27 2013
  278. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report, WORLD JOURNAL OF SURGICAL ONCOLOGY, 12, FEB 27 2014
  279. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer, INTERNATIONAL JOURNAL OF CANCER, 134(8), 1926-1934, APR 15 2014
  280. Association of Increased Indoleamine 2, 3-Dioxygenase With Impaired Natural Killer Cell Activity in Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 18(1), 19-23, FEB 2014
  281. Colonoscopy as a tool for evaluating colorectal tumor development in a mouse model, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29(2), 217-223, FEB 2014
  282. Clinical Efficacy of Simultaneous Splenectomy in Liver Transplant Recipients With Hepatitis C Virus, TRANSPLANTATION PROCEEDINGS, 46(3), 770-773, APR 2014
  283. Bile CXC Motif Chemokine 10 Levels Correlate With Anti-donor Cytotoxic T Cell Responses After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 790-793, APR 2014
  284. Risk Factors for Development of New-Onset Diabetes Mellitus and Progressive Impairment of Glucose Metabolism After Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 865-869, APR 2014
  285. Multiple Hepatic Vein Reconstruction Using an All-in-one Sleeve Patch Graft Technique in Living Donor Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 46(3), 982-985, APR 2014
  286. Ischemia-reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery, SURGERY TODAY, 44(9), 1611-1625, SEP 2014
  287. The Usefulness of Preoperative 18FDG Positron-Emission Tomography and Computed Tomography for Predicting the Malignant Potential of Gastrointestinal Stromal Tumors, DIGESTIVE SURGERY, 31(2), 79-86, 2014
  288. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation, HEPATO-GASTROENTEROLOGY, 61(133), 1387-1392, JUL-AUG 2014
  289. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, BREAST CANCER, 21(5), 571-575, SEP 2014
  290. Validation of a novel basic virtual reality simulator, the LAP-X, for training basic laparoscopic skills, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 23(5), 287-293, OCT 2014
  291. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation, HEPATOLOGY RESEARCH, 44(12), 1259-1264, NOV 2014
  292. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis, WORLD JOURNAL OF GASTROENTEROLOGY, 21(6), 1982-1988, 20150214
  293. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells, INTERNATIONAL JOURNAL OF CANCER, 136(4), E3-E13, FEB 15 2015
  294. Rho-Kinase Inhibitor Targeting the Liver Prevents Ischemia/Reperfusion Injury in the Steatotic Liver Without Major Systemic Adversity in Rats, LIVER TRANSPLANTATION, 21(1), 123-131, JAN 2015
  295. Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipients, HUMAN IMMUNOLOGY, 75(12), 1259-1267, DEC 2014
  296. Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity, Nature Communications, 6, JAN 2015
  297. Impact of Rituximab Desensitization on Blood-Type-Incompatible Adult Living Donor Liver Transplantation: A Japanese Multicenter Study, AMERICAN JOURNAL OF TRANSPLANTATION, 14(1), 102-114, JAN 2014
  298. Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion, CANCER SCIENCE, 105(11), 1411-1420, NOV 2014
  299. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, DEC 2014
  300. Initial experiences of robotic versus conventional laparoscopic surgery for colorectal cancer, focusing on short-term outcomes: a matched case-control study, WORLD JOURNAL OF SURGICAL ONCOLOGY, 13, MAR 12 2015
  301. Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case, WORLD JOURNAL OF SURGICAL ONCOLOGY, 13, MAR 26 2015
  302. Fasting Enhances TRAIL-Mediated Liver Natural Killer Cell Activity via HSP70 Upregulation, PLOS ONE, 9(10), OCT 30 2014
  303. Retention of robot-assisted surgical skills in urological surgeons acquired using Mimic dV-Trainer, CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 8(7-8), E493-E497, JUL 2014
  304. Intrahepatic triglyceride measurement and estimation of viability in rat fatty livers by near-infrared spectroscopy, HEPATOLOGY RESEARCH, 45(4), 470-479, APR 2015
  305. The significance of spatial cognitive ability in robot-assisted surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(5), 1130-1136, MAY 2015
  306. Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report, TRANSPLANTATION PROCEEDINGS, 47(3), 809-814, APR 2015
  307. Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection, ANNALS OF THORACIC SURGERY, 99(5), 1746-1754, MAY 2015
  308. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases, WORLD JOURNAL OF SURGICAL ONCOLOGY, 13, APR 24 2015
  309. Hepatic Sclerosed Hemangioma: a case report and review of the literature, BMC SURGERY, 15, APR 17 2015
  310. Laparoscopic Versus Open Surgery for Colorectal Cancer in Elderly Patients: A Multicenter Matched Case-Control Study, ANNALS OF SURGICAL ONCOLOGY, 22(6), 2040-2050, JUN 2015
  311. Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, LANGENBECKS ARCHIVES OF SURGERY, 400(4), 471-476, MAY 2015
  312. Administration of Antithrombin III Attenuates Posthepatectomy Liver Failure in Hepatocellular Carcinoma, DIGESTIVE SURGERY, 32(3), 173-180, 2015
  313. An evaluation of the endoscopic surgical skills assessment using a video analysis software program, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(7), 1804-1808, JUL 2015
  314. Small bowel obstruction due to an unconjugated ursodeoxycholic acid enterolith following living donor liver transplantation: Report of a case, HEPATOLOGY RESEARCH, 45(7), 818-822, JUL 2015
  315. Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice, PLOS ONE, 10(7), JUL 17 2015
  316. Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery, SURGERY TODAY, 45(8), 986-992, AUG 2015
  317. A case of gastric cancer following living donor liver transplantation, Hiroshima J Med Sci, 63(1-3), 23-26, 2014,Sep
  318. Body mass index as a predictor of postoperative complications in loop ileostomy closure after rectal resection in Japanese patients., Hiroshima J Med Sci, 63(4), 33-38, 2014,Dec
  319. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers., PLoS One, 9(12), e114263. doi: 10.1371, 2014,12,19
  320. Integrated Analysis of Whole Genome and Transcriptome Sequencing Reveals Diverse Transcriptomic Aberrations Driven by Somatic Genomic Changes in Liver Cancers, HEPATOLOGY RESEARCH, 44(12), 201411
  321. Integrated Analysis of Whole Genome and Transcriptome Sequencing Reveals Diverse Transcriptomic Aberrations Driven by Somatic Genomic Changes in Liver Cancers, PLOS ONE, 2014
  322. Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey, TRANSPLANT INTERNATIONAL, 2014
  323. Sulindac delayed and suppressed the tumor progression, was not effective on inhibition of tumor initiation in a human colorectal cancer mouse model (CPC;Apc mouse), CANCER RESEARCH
  324. Inflammatory markers as predictors of surgical site infection after elective colorectal surgery: authors' reply
  325. Association of Fc-gamma Receptor Gene Polymorphisms With Susceptibility to Bloodstream Infections After Liver Transplantation, TRANSPLANTATION, 2014
  326. Adoptive Immunotherapy With Deceased Donor Derived-Liver Natural Killer (NK) Cells Is Well Tolerated and Has the Potential to Become a Powerful Therapeutic Tool for Preventing Recurrence of Hepatocellular Carcinoma After Liver Transplantation, TRANSPLANTATION, 2014
  327. Impact of Natural Killer Cell Licensing Associated With KIR-HLA Genotype On the Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy: Can the KIR-HLA Genotype Be a Selection Criterion for Potential Donors for Liver Transplantation With Adoptive Immunotherapy Using NK Cells Extracted From Liver Allografts?, TRANSPLANTATION, 2014
  328. Blockade of CD47-Signaling Regulatory Protein alpha Signaling Enhances the Macrophage Phagocytic Activity Against Cancer Cells, TRANSPLANTATION, 2014
  329. Influence of Adoptive Immunotherapy Employing Allograft Liver-Resident Lymphocytes On Alloimmune Responses., TRANSPLANTATION, 2014
  330. Liver DX5(-) Natural Killer Cells Play a Crucial Role On Instant Blood-Mediated Inflammatory Reaction After Islet Transplantation., TRANSPLANTATION, 201407
  331. The Impact of Toll-Like Receptor Signaling On B Cells Responding to Blood Group A Carbohydrates, TRANSPLANTATION, 201407
  332. Postoperative Portal Hypertension Accelerates Alloimmune Responses in Recipients After Living Donor Liver Transplantation By Impairing Antigen Presenting Capacity of Liver Sinusoidal Endothelial Cells, TRANSPLANTATION, 201407
  333. FOXP3 Gene rs3761548 A Carriers Are Susceptible to Acute Cellular Rejection in Living Donor Liver Transplantation, TRANSPLANTATION, 201407
  334. Novel Adjuvant Immunotherapy Using Liver Natural Killer Cells for Preventing Recurrence of Hepatocellular Carcinoma in Liver Transplantation, LIVER TRANSPLANTATION, 201406
  335. The Impact of Fc gamma Receptor Polymorphism on Infection-Related Complications in ABO-Incompatible Living Donor Liver Transplantation Under Rituximab-Based Immunosuppressive Regimen, LIVER TRANSPLANTATION
  336. Generation of NK Cells from Hematopoietic Stem Cells In Vitro for Anti-HCV and Anti-HCC Immunotherapy: Evaluation Using Human Hepatocyte Chimeric Mice, LIVER TRANSPLANTATION, 201406
  337. Risk Factors of the Hepatocellular Carcinoma Recurrence after Living Donor Liver Transplantation; a Single Center Experience Retrospective Analysis, LIVER TRANSPLANTATION, 201406
  338. Preoperative Prophylaxis With Itraconazole Can Prevent Fungal Infection after Liver Transplantation, LIVER TRANSPLANTATION, 201406
  339. Association of Fc-gamma Receptor Gene Polymorphisms With Susceptibility to Bloodstream Infections After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 201406
  340. Adoptive Immunotherapy With Deceased Donor Derived-Liver Natural Killer (NK) Cells Is Well Tolerated and Has the Potential to Become a Powerful Therapeutic Tool for Preventing Recurrence of Hepatocellular Carcinoma After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 201406
  341. Impact of Natural Killer Cell Licensing Associated With KIR-HLA Genotype On the Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy: Can the KIR-HLA Genotype Be a Selection Criterion for Potential Donors for Liver Transplantation With Adoptive Immunotherapy Using NK Cells Extracted From Liver Allografts?, AMERICAN JOURNAL OF TRANSPLANTATION
  342. Blockade of CD47-Signaling Regulatory Protein alpha Signaling Enhances the Macrophage Phagocytic Activity Against Cancer Cells, AMERICAN JOURNAL OF TRANSPLANTATION
  343. Influence of Adoptive Immunotherapy Employing Allograft Liver-Resident Lymphocytes On Alloimmune Responses, AMERICAN JOURNAL OF TRANSPLANTATION
  344. Liver DX5-Natural Killer Cells Play a Crucial Role On Instant Blood-Mediated Infl ammatory Reaction After Islet Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION
  345. The Impact of Toll-Like Receptor Signaling On B Cells Responding to Blood Group A Carbohydrates, AMERICAN JOURNAL OF TRANSPLANTATION
  346. Postoperative Portal Hypertension Accelerates Alloimmune Responses in Recipients After Living Donor Liver Transplantation By Impairing Antigen Presenting Capacity of Liver Sinusoidal Endothelial Cells, AMERICAN JOURNAL OF TRANSPLANTATION
  347. FOXP3 Gene rs3761548 A Carriers Are Susceptible to Acute Cellular Rejection in Living Donor Liver Transplantation., AMERICAN JOURNAL OF TRANSPLANTATION
  348. Clinical Efficacy of Simultaneous Splenectomy in Liver Transplant Recipients With Hepatitis C Virus, TRANSPLANTATION PROCEEDINGS
  349. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS
  350. Bile CXC Motif Chemokine 10 Levels Correlate With Anti-donor Cytotoxic T Cell Responses After Liver Transplantation, TRANSPLANTATION PROCEEDINGS
  351. Risk Factors for Development of New-Onset Diabetes Mellitus and Progressive Impairment of Glucose Metabolism After Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS
  352. Response: Domino liver transplantation as a valuable option, TRANSPLANT INTERNATIONAL
  353. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report, WORLD JOURNAL OF SURGICAL ONCOLOGY
  354. Association of Increased Indoleamine 2, 3-Dioxygenase With Impaired Natural Killer Cell Activity in Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS
  355. Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice, JOURNAL OF VIROLOGY, 89(19), 10087-10096, OCT 2015
  356. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, SEP 2015
  357. The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer, SURGERY TODAY, 45(11), 1396-1403, NOV 2015
  358. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer, PATHOBIOLOGY, 82(5), 233-241, 2015
  359. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy, EJSO, 41(11), 1515-1521, 201511
  360. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, OCT 2015
  361. Stochastic resonance enhanced tactile feedback in laparoscopic surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(12), 3811-3818, DEC 2015
  362. Prophylactic managements of hepatitis B viral infection in liver transplantation, WORLD JOURNAL OF GASTROENTEROLOGY, 22(1), 165-175, JAN 7 2016
  363. Laparoscopic surgery for colorectal cancer is safe and has survival outcomes similar to those of open surgery in elderly patients with a poor performance status: subanalysis of a large multicenter case-control study in Japan, JOURNAL OF GASTROENTEROLOGY, 51(1), 43-54, JAN 2016
  364. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 8-14, 2016
  365. An Analysis of Surgical Treatment for the Spontaneous Rupture of Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 43-50, 2016
  366. Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation, HEPATOLOGY RESEARCH, 45(11), 1047-1054, NOV 2015
  367. The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway, TRANSPLANTATION, 99(11), 2325-2336, NOV 2015
  368. Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 16(2), 625-633, FEB 2016
  369. Long-term outcomes after treatment for T1 colorectal carcinoma, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 31(3), 571-578, MAR 2016
  370. The Incidence of Posthepatectomy Liver Failure Defined by the International Study Group of Liver Surgery among Living Donors, JOURNAL OF GASTROINTESTINAL SURGERY, 20(4), 757-764, APR 2016
  371. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 22, 75-78, 2016
  372. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer, NATURE GENETICS, 48(5), 500-+, MAY 2016
  373. Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 20, 96-100, 2016
  374. Enhanced recovery program is safe and improves postoperative insulin resistance in gastrectomy, WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 8(5), 382-388, MAY 27 2016
  375. h-prune affects anaplastic thyroid cancer invasion and metastasis, ONCOLOGY REPORTS, 35(6), 3445-3452, JUN 2016
  376. Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs, LANGENBECKS ARCHIVES OF SURGERY, 401(4), 513-517, JUN 2016
  377. Effect of Spatial Cognitive Ability on Gain in Robot-Assisted Surgical Skills of Urological Surgeons, JOURNAL OF SURGICAL EDUCATION, 73(4), 624-630, JUL-AUG 2016
  378. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation, HUMAN IMMUNOLOGY, 77(6), 456-463, JUN 2016
  379. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases, INTERNATIONAL JOURNAL OF CANCER, 139(4), 812-823, AUG 15 2016
  380. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma, CANCER MEDICINE, 5(7), 1546-1555, JUL 2016
  381. Chemotherapeutic outcomes for metastatic colorectal cancer in elderly patients aged >= 75 years: A single-institutional retrospective analysis, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 12(2), 151-158, JUN 2016
  382. Increased Calcineurin A Expression Is Associated with a Lower Relapse-Free Survival Rate after Colorectal Cancer Surgery, PATHOBIOLOGY, 83(6), 308-315, 2016
  383. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report, HEPATOLOGY RESEARCH, 46(7), 707-712, JUN 2016
  384. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, JUN 2016
  385. KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer, ONCOGENESIS, 5, AUG 2016
  386. The usefulness of 3-dimensional endoscope systems in endoscopic surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(10), 4562-4568, OCT 2016
  387. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma, JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 40(4), 524-530, JUL-AUG 2016
  388. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, SEP 9 2016
  389. Successful treatment of primary advanced gastric plasmacytoma using a combination of surgical resection and chemotherapy with bortezomib: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 27, 133-136, 2016
  390. De novo renal cell carcinoma in a kidney allograft 20 years after transplant, Case Rep Transplant, 679262-679262, 2015
  391. How can we minimize bleeding complications in ABO-incompatible kidney transplant recipients?, Transpl Int., 28(1), 22-24, 2015,01
  392. A case of biliary cystic tumor with repeated hemobilia, Surg Case Rep, 1(1), 34-34, 2015 DEC
  393. Risk Factors for the Development of Desmoid Tumor After Colectomy in Patients with Familial Adenomatous Polyposis: Multicenter Retrospective Cohort Study in Japan, ANNALS OF SURGICAL ONCOLOGY, 23, 559-565, AUG 2016
  394. CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment, PLOS ONE, 11(8), AUG 25 2016
  395. Role of Src Family Kinases in Regulation of Intestinal Epithelial Homeostasis, MOLECULAR AND CELLULAR BIOLOGY, 36(22), 2811-2823, NOV 2016
  396. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study, JOURNAL OF VIRAL HEPATITIS, 23(11), 850-856, NOV 2016
  397. Laparoscopic extra-abdominal suturing technique for the repair of Larrey's diaphragmatic hernia using the port closure needle (Endo Close (R)): A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 28, 34-37, 2016
  398. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation, PLOS ONE, 11(11), NOV 11 2016
  399. Surgical Grasping Forceps With Enhanced Sensorimotor Capability via the Stochastic Resonance Effect, IEEE-ASME TRANSACTIONS ON MECHATRONICS, 21(6), 2624-2634, DEC 2017
  400. Single-incision laparoscopic excision of a chylous mesenteric cyst: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 29, 254-257, 2016
  401. Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey, TRANSPLANTATION DIRECT, 2(6), JUN 2016
  402. A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study, SPRINGERPLUS, 5, OCT 18 2016
  403. KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells, ANTICANCER RESEARCH, 37(1), 47-55, JAN 2017
  404. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer, ANNALS OF SURGICAL ONCOLOGY, 24(2), 594-602, FEB 2017
  405. MELD and Child-Pugh Scores Are Related to Immune Status of Intrahepatic Natural Killer Cells in Liver Transplant Candidates, TRANSPLANTATION PROCEEDINGS, 49(1), 98-101, 2017
  406. Role of Natural Killer Cells in the Innate Immune System After Intraportal Islet Transplantation in Mice, TRANSPLANTATION PROCEEDINGS, 49(1), 139-144, 2017
  407. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors, JOURNAL OF HEPATOLOGY, 66(2), 363-373, 201702
  408. Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus, PLOS ONE, 12(3), 20170302
  409. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 49-57, 201701
  410. Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 58-64, 201701
  411. Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 31, 5-9, 2017
  412. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients, JOURNAL OF GASTROENTEROLOGY, 52(3), 366-375, 201703
  413. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, 201612
  414. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 39, 206-213, 201703
  415. Possible role of soluble fibrin monomer complex after gastroenterological surgery, WORLD JOURNAL OF GASTROENTEROLOGY, 23(12), 2209-2216, 20170328
  416. Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report, SURGICAL CASE REPORTS, 2, DEC 7 2016
  417. Simeprevir or telaprevir with peginterferon and ribavirin for recurrent hepatitis C after living-donor liver transplantation: A Japanese multicenter experience, HEPATOLOGY RESEARCH, 46(13), 1285-1293, DEC 2016
  418. Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients., HUMAN IMMUNOLOGY, 78(4), 357-362, 201704
  419. De Garengeot hernia with perforated appendicitis and a groin subcutaneous abscess: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 33, 8-11, 2017
  420. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy, ANTICANCER RESEARCH, 37(5), 2625-2631, 201705
  421. Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report, SURGICAL CASE REPORTS, 3, 20170525
  422. Effects of nutritional supplementation with selenium and zinc on natural killer cell activity in hemodialysis patients: a single-arm study, INTERNATIONAL UROLOGY AND NEPHROLOGY, 48(8), 1377-1378, AUG 2016
  423. PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice, PLOS ONE, 12(5), 2017
  424. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma, WORLD JOURNAL OF SURGERY, 41(7), 1860-1870, 2017
  425. Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication, TRANSPLANTATION PROCEEDINGS, 49(5), 1160-1164, 201706
  426. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection, HEPATOLOGY RESEARCH, 47(8), 767-772, 201707
  427. New noncontact sensor for detecting pulmonary tumors during video-assisted thoracic surgery, JOURNAL OF SURGICAL RESEARCH, 214, 62-68, 20170615
  428. Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas, LANGENBECKS ARCHIVES OF SURGERY, 402(5), 745-755, 201708
  429. Patients with early recurrence of hepatocellular carcinoma have poor prognosis, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 16(3), 279-288, 201706
  430. A case of cholangiolocellular carcinoma featuring intratumoral hepatic artery penetration: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 35, 77-81, 2017
  431. Application of endobronchial ultrasonography in laparoscopic liver segmentectomy in an animal model, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 10(2), 209-212, 201705
  432. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis, INTERNATIONAL JOURNAL OF SURGERY, 42, 209-214, 201706
  433. PERIOSTIN PROMOTES MALIGNANT POTENTIAL BY INDUCTION OF EPITHELIAL-MESENCHYMAL TRANSITION IN INTRAHEPATIC CHOLANGIOCARCINOMA, GASTROENTEROLOGY, 152(5), S803-S803, 2017
  434. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 44, 223-228, 2017
  435. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer, JOURNAL OF PATHOLOGY, 243(1), 100-110, 2017
  436. Should organs from hepatitis C virus-infected donors be used for transplantation in the era of DAAs?, TRANSPLANT INTERNATIONAL, 30(9), 860-862, 2017
  437. Impact of comorbidities on the postoperative outcomes of acute cholecystitis following early cholecystectomy, SURGERY TODAY, 47(10), 1230-1237, 2017
  438. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver (vol 48, pg 500, 2016), NATURE GENETICS, 48(5), 2016
  439. Effect of Spatial Cognitive Ability on Gain in Robot-Assisted Surgical Skills of Urological Surgeons, JOURNAL OF SURGICAL EDUCATION, 73(4), 624-630, 2016
  440. Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 23(6), 333-341, 2016
  441. ADOPTIVE IMMUNOTHERAPY WITH ACTIVATED NK CELLS EXTRACTED FROM A LIVER ALLOGRAFT PERFUSATE COMPENSATES FOR THE GENETIC SUSCEPTIBILITY TO BLOODSTREAM INFECTION AFTER LIVER TRANSPLANTATION, TRANSPLANT INTERNATIONAL, 28, 199-199, 2015
  442. BACTERIAL PATHOGENS PROVOKE B CELLS RESPONDING TO BLOOD GROUP A-ANTIGENS TO BE RESISTANT TO CALCINEURIN INHIBITORS THROUGH TLR-MYD88 PATHWAY., TRANSPLANTATION, 99(11), S2-S2, 2015
  443. PROPAGATED NK CELLS FROM HUMAN PLURIPOTENT STEM CELLS EXERT VIGOROUS CYTOTOXICITY AGAINST HCC AND INHIBIT HCV REPLICATION., TRANSPLANTATION, 99(11), S8-S8, 2015
  444. IDENTIFICATION OF A NOVEL TOLEROGENIC B CELL SUBCLASS CO-EXPRESSING BOTH OF PD-L1/PD-L2 TO INHIBIT ALL-REACTIVE T CELLS., TRANSPLANTATION, 99(11), S14-S14, 2015
  445. UP-REGULATION OF ANTI-TUMOR ACTIVITY ON LIVER NK CELLS UNDER THE FASTING CONDITION., TRANSPLANTATION, 99(11), S18-S18, 2015
  446. LIVER-RESIDENT NATURAL KILLER CELLS EXPOSED TO INSTANT BLOOD-MEDIATED INFLAMMATORY REACTION AFTER INTRAPORTAL ISLET TRANSPLANTATION PERSISTENTLY SUSTAIN MEMORY PHENOTYPE WITH CYTOTOXICITY AGAINST ISLETS., TRANSPLANTATION, 99(11), S19-S19, 2015
  447. A Novel Approach for Preventing HCC Recurrence after LT: Adoptive Immunotherapy Using Donor Liver Natural Killer Cells To Prevent Hepatocellular Carcinoma Recurrence after Liver Transplantation, TRANSPLANTATION, 99, 111-111, 2015
  448. Gene expression profiling for oncogenic Kras mutation in mice and human colorectal cancer, CANCER RESEARCH, 75, 2015
  449. The generation of colorectal cancer mouse model based on microsatellite instability and the identification of transforming growth factor-beta signal target, CANCER RESEARCH, 75, 2015
  450. Impact of synbiotics administration on tumorigenesis of colon cancer mouse model, CANCER RESEARCH, 75, 2015
  451. Whole genome sequencing analysis of multiple liver cancer nodules for determination of causal events for multi-occurrence, CANCER RESEARCH, 75, 2015
  452. Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter, Surg Case Rep, 2(1), 89-89, 201612
  453. Assessment of cancer pain in a patient with communication difficulties: a case report, J Med Case Rep, 10(1), 148, 20160602
  454. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 44, 223-228, 201708
  455. Aggressive angiomyxoma of the liver: a case report and literature review, SURGICAL CASE REPORTS, 3, 20170823
  456. Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 49(7), 1634-1638, 201709
  457. Propensity score-matching analysis of the efficacy of late cholecystectomy for acute cholecystitis, AMERICAN JOURNAL OF SURGERY, 214(2), 262-266, 201708
  458. Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response, HEPATOLOGY RESEARCH, 47(11), 1186-1195, 201710
  459. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation, TRANSPLANT INFECTIOUS DISEASE, 19(5), 201710
  460. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma, ANTICANCER RESEARCH, 37(10), 5863-5870, 201710
  461. Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation, CLINICAL JOURNAL OF GASTROENTEROLOGY, 10(2), 179-184, 201704
  462. Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice, PLOS ONE, 12(10), 20171031
  463. Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience, CLINICAL TRANSPLANTATION, 31(11), 201711
  464. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer, Hiroshima J Med Sci, 57(2), 73-78, 2008
  465. Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus, ANNALS OF TRANSPLANTATION, 22, 701-706, 20171124
  466. Mixed adenoneuroendocrine carcinoma derived from the cystic duct: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 39, 29-33, 2017
  467. Invasive micropapillary carcinoma component is an independent prognosticator of poorer survival in Stage III colorectal cancer patients, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47(12), 1129-1134, 201712
  468. Complete pathological response of multiple huge liver metastases of colon cancer: a case report, OXFORD MEDICAL CASE REPORTS, 54-57, 201705
  469. 3D printing model of the intrahepatic vessels for navigation during anatomical resection of hepatocellular carcinoma, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 41, 219-222, 2017
  470. Role of Src Family Kinases in Regulation of Intestinal Epithelial Homeostasis, MOLECULAR AND CELLULAR BIOLOGY, 36(22), 2811-2823, 2016
  471. CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment, PLOS ONE, 11(8), 2016
  472. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases, INTERNATIONAL JOURNAL OF CANCER, 139(4), 812-823, 2016
  473. Risk Factors for the Development of Desmoid Tumor After Colectomy in Patients with Familial Adenomatous Polyposis: Multicenter Retrospective Cohort Study in Japan, ANNALS OF SURGICAL ONCOLOGY, 23, 559-565, 2016
  474. Effects of nutritional supplementation with selenium and zinc on natural killer cell activity in hemodialysis patients: a single-arm study, INTERNATIONAL UROLOGY AND NEPHROLOGY, 48(8), 1377-1378, 2016
  475. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation, PLOS ONE, 11(11), 2016
  476. A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study, SPRINGERPLUS, 5, 2016
  477. Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus, PLOS ONE, 12(3), 2017
  478. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, 2016
  479. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 39, 206-213, 2017
  480. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 49-57, 2017
  481. Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 58-64, 2017
  482. Possible role of soluble fibrin monomer complex after gastroenterological surgery, WORLD JOURNAL OF GASTROENTEROLOGY, 23(12), 2209-2216, 2017
  483. Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients., HUMAN IMMUNOLOGY, 78(4), 357-362, 2017
  484. Patients with early recurrence of hepatocellular carcinoma have poor prognosis, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 16(3), 279-288, 2017
  485. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection, HEPATOLOGY RESEARCH, 47(8), 767-772, 2017
  486. New noncontact sensor for detecting pulmonary tumors during video-assisted thoracic surgery, JOURNAL OF SURGICAL RESEARCH, 214, 62-68, 2017
  487. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis, INTERNATIONAL JOURNAL OF SURGERY, 42, 209-214, 2017
  488. Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas, LANGENBECKS ARCHIVES OF SURGERY, 402(5), 745-755, 2017
  489. Prophylactic managements of hepatitis B viral infection in liver transplantation, WORLD JOURNAL OF GASTROENTEROLOGY, 22(1), 165-175, 2016
  490. The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer, SURGERY TODAY, 45(11), 1396-1403, 2015
  491. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, 2015

Publications such as books

  1. 2015, Surveillance of de novo malignancy after living-donor liver transplantation, 2015

Invited Lecture, Oral Presentation, Poster Presentation

  1. 80 歳以上の高齢者根治切除施行大腸がん手術症例におけるBMI による解析, 安達智洋,檜井孝夫, 川口康夫, 大段秀樹, 金澤旭宣, 中西正芳, 久保義郎, 伊藤雅昭, 猪俣雅史, 伴登宏行, 八岡利昌, 植木隆, 渡邊昌彦., 第116回日本外科学会定期学術集会, Without Invitation
  2. Adjuvant immunotherapy using liver NKCells enhances protective immunity against HCC recurrence and infectious complications in live rtransplantation., 2014/04/03, With Invitation
  3. Controlling Anti-Carbohydrate Antibody Responses in Xenotransplantation, WTC2014, 2014/07/26, Without Invitation
  4. Impact of Fc-gamma receptor gene polymorphisms on susceptibility to infectious complication after liver transplantation, Japan Korea Transplantation Forum 2014, 2014/09/12, Without Invitation
  5. Immunological feature of liver transplant recipients infected with HBV, 2014/11/20, Without Invitation
  6. Hepatocellular carcinoma patients who radiologically meet but pathologically exceed the Milan criteria are susceptible to recurrence after living-donor liver transplantation, Hideki Ohdan, 2015/06/11, With Invitation, tokyo
  7. New approaches for ABO-mismatched solid organ transplantation., Hideki Ohdan, The 25th Regional Congress of the ISBT 2015, 2015/06/29, With Invitation, ISBT, LONDON
  8. The depletion of liver natural killer cells lead to successful engraftment of intraportal transplanted islet when insufficient number of islets used for islet transplantation, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., 2016/04, Without Invitation
  9. Distinct sensitivity of B-1a/B-1b/B-2 cell subpopulations to immunosuppressants, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  10. The depletion of liver natural killer cells lead to successful engraftment of intraportal transplanted islet when insufficient number of islets used for islet transplantation, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  11. The Alcohol Use Disorder Identification Test-Consumption (AUDIT-C) predicts the risk of excessive alcohol consumption in patients after liver transplantation, Yano T, Ohira M, Sakamoto R, Narisada A, Tahara H, Ide K, Ishiyama K, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  12. The phenotypic and functional distinction between B cells with receptors for human blood group A and B antigens, Sakai H,Tanaka Y, Masahiro Y, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  13. Assessment using a novel predictive value and treatment for steroid-resistant acute cellular rejection after liver transplantation, Tahara H,Ishiyama K, Ide K, Tanaka Y, Ohira M, Tanimine N, Shimizu S, Kobayashi T, Ohdan H, Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  14. 術中内視鏡を併用し根治切除しえた十二指腸腺腫・粘膜内癌の4例, 山本悠司,田邊和照, 堀田龍一, 佐伯吉弘, 竹原寛樹 大段秀樹., 第118回広島消化器病研究会, 2016/04, Without Invitation
  15. 消化器外科手術後における静脈血栓塞栓症の発症予測マーカーとしての可溶性フィブリンモノマー複合体(Soluble fibrin monomer complex,SFMC)の意義, 河内雅年,下村学, 檜井孝夫, 田邊和照, 惠木浩之, 石崎康代, 安達智洋, 田代裕尊, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  16. 肝移植術後重症感染症の起因菌推測と抗生剤選択における自然免疫遺伝子多型の意義, 清水誠一,田中友加, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 谷峰直樹, 佐伯吉弘, 坂井寛, 矢野琢也, 小林剛, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  17. 80 歳以上の高齢者根治切除施行大腸がん手術症例におけるBMI による解析, 安達智洋,檜井孝夫, 川口康夫, 大段秀樹, 金澤旭宣, 中西正芳, 久保義郎, 伊藤雅昭, 猪俣雅史, 伴登宏行, 八岡利昌, 植木隆, 渡邊昌彦., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  18. 大腸癌肝転移切除症例におけるGlasgow Prognostic Score の意義, 沖本将,小林剛, 田代裕尊, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 黒田慎太郎, 谷峰直樹, 岩子寛, 橋本昌和, 濱岡道則, 惠木浩之, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  19. 肝細胞癌切除後の肝外再発予測因子, 橋本昌和,小林剛, 田代裕尊, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 黒田慎太郎, 岩子寛, 濱岡道則, 沖本将, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  20. 細菌感染症により誘発される難治性抗体関連拒絶反応の新規メカニズムの解明, 坂井寛,田中友加, 山下正博, 佐々木由布, 中野亮介, 田口和浩, 石田伸樹, 柳川泉一郎, 矢野琢也, 佐伯吉弘, 清水誠一, 谷峰直樹, 大平真裕, 田原裕之, 井手健太郎, 石山宏平, 尾上隆司, 田代裕尊, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  21. Significant association of Vitamin-D Receptor (VDR) Gene Polymorphism and Incidence od De Novo DSA in Renal Transplantation, Das Lalit Kumar,Ide K, Tanaka Y, Tanimine N, Verma S, Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation
  22. Significant association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation Phase., Das Lalit Kumar,K.Ide, Y.Tanaka, S.Shimizu, N.Tanimine, S.Verma, H.Ohdan, American Transplant Congress 2016, 2016/06, Without Invitation
  23. Impact of Immunosuppressants on Inducing Regulatory T Cells in Human Allo-Immune Responses., Tanaka Y,Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation
  24. Cross-Talk Between TLR and BCR Pathways Induces CNI-Resistance in B-Cells Responding to Blood Group A-Antigens: A Novel Paradigm for Treatment with TLR-Inhibitor for CNI-Resistant AMR., Sakai H,Tanaka Y, Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation
  25. Immunotherapy using donor liver NK cells for preventing severe infection after liver transplantation, 2016/07, Without Invitation
  26. Liver DX5- memory natural killer cells sustain cytotoxicity against intraportally transplanted islet, 2016/07, Without Invitation
  27. Cotransplantation of preactivated mesenchymal stem cells inhibits liver natural killer cell–induced islet graft injury during instant blood-mediated inflammatory reaction after syngeneic intraportal islet transplantation, Ishida N,Ohdan H, Ishiyama K, Saeki Y, Tanaka Y, Tahara H, Verma S, Saparbay D, Sasaki Y, Onoe T, Ohira M, Yano T, Yanagawa S, Taguchi K, Piao J, Tanaka A, Ide K, Shimizu S, Das L K, Nakano R., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  28. Negative influence of liver irradiation on liver resident NK cells., Nakano R,Ohira M, Yano T, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  29. Long-lasting expansion of memory-like natural killer cells in the liver after intraportal syngeneic islet transplantation in mice, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  30. Various pathogenic microbes induce CNI-resistance in B-cells responding to blood group antigens through TLR-MyD88 pathway, Sakai H,Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  31. Clinical and immunological significance of controlling portal vein pressure in living donor liver transplantation, Taguchi K,Onoe T, Hashimoto S, Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  32. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation., Tanaka A ,Morimoto H, IdeK, Tanaka Y, Ishiyama K, Ohira M, Tahara H, Shimizu S, Saeki Y, Sakai H, Tano T, Ishida N, Yanagawa S, Tagushi K, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  33. Human endothelial-like cells transdifferentiated from monocytes suppress allo-reactive T cells, Tanaka Y,Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  34. Development of an anti-HLA antibody-producing humanized mouse model, Yanagawa S,Tahara H, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  35. Reduction in CXCL9–CXCR3 signals diminishes TRAIL-expressing liver NK cells in partially hepatectomized mice under depressed immune status., Yano T、Ohira M, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  36. 生体肝移植後にニューモシスチス・カリニ肺炎を発症しveno-venous Extra corporeal membrane oxygenation(vv-ECMO)にて救命し得た1例, 秋本修志 、田原裕之, 高橋元, 中島一記, 田口和浩, 田中飛鳥, 中野亮介, 石田伸樹, 柳川泉一郎, 矢野琢也, 坂井寛, 佐伯吉弘, 清水誠一, 大平真裕, 井手健太郎, 石山宏平, 黒田慎太郎, 小林剛, 大段秀樹., 2016/08, Without Invitation
  37. von Willebrand病患者において安全に肝切除術を施行し得た1例, 2016/09, Without Invitation
  38. 切除不能進行胃癌に対するConversion Surgeryの可能性 -胃癌肝転移に対する肝切除の適応基準の確立を目指して-, 堀田龍一、田邊和照, 鈴木崇久, 三隅俊博, 佐伯吉弘, 山本悠司, 竹原寛樹, 柳川泉一郎, 高橋元, 大段秀樹., 第91回中国四国外科学会総会, 2016/09, Without Invitation
  39. 持続性ウイルス学的著効後に発症したC型肝炎関連肝細胞癌に対する肝切除後再発予測因子の検討, 沖本将、小林剛, 黒田慎太郎, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 清水誠一, 岩子寛, 濱岡道則, 本明慈彦, 山口恵美, 大段秀樹., 第91回中国四国外科学会総会, 2016/09, Without Invitation
  40. 局所進行直腸癌に対する術前化学放射線療法(CRT)の検討, 寿美裕介、惠木浩之、佐田春樹、安達智洋、向井正一郎、河内雅年、矢野琢也、田口和浩、中島一記、大段秀樹, 第91回中国四国外科学会総会, 2016/09, Without Invitation
  41. 同時性大腸癌腹膜播種症例における術前mGPSによる治療選択の検討, 田口和浩 安達智洋、惠木浩之、向井正一朗、矢野琢也、河内雅年、佐田春樹、寿美裕介、中島一記、田邊和昭、大段秀樹, 第110回広島がん治療研究会, 2016/09, Without Invitation
  42. 肝細胞癌に対する治癒切除症例の肝外再発予測因子, 本明慈彦 小林剛、橋本昌和、黒田慎太郎、石山宏平、井手健太郎、大平真裕、田原裕之、岩子寛、濱岡道則、沖本将、山口恵美、大段秀樹, 第110回広島がん治療研究会, 2016/09, Without Invitation
  43. ABO血液型不適合移植における脱感作療法(腎移植・肝移植), 2016/09, With Invitation
  44. 臓器移植におけるATGの役割, 大段秀樹, 第52回日本移植学会総会, 2016/09, With Invitation
  45. 清水誠一 田中友加, 大平真裕, 石山宏平, 井手健太郎, 田原裕之, 佐伯吉弘, 坂井寛, 矢野琢也, 小林剛, 大段秀樹., 2016/09, Without Invitation
  46. 広島大学における急性肝不全症例に対する肝移植の検討, 2016/09, Without Invitation
  47. Toll-like receptor阻害剤を用いた新たな血液型抗原応答B細胞特異的制御法の基礎的解析, 2016/09, Without Invitation
  48. Expression of Signal peptidase complex 18 is associated with poor survival of patients with esophageal cancer, yuji yamamoto Naohide Oue, Takeharu Imai, Naoya Sakamoto, Kazuhiro Sentani, Hideki Ohdan, Wataru Yasui, 2016/10, Without Invitation
  49. Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: An exploratory study of the randomized phase II COMPASS tria, Tanabe K Yoshikawa T, Oshima Y, Miyagi S, Morita K, Nishikawa Y, Ito T, Matsui Y, Kimura T, Aoyama T, Hayashi T, Ogata H, Cho A, Tuburaya J, Sakamoto, ESMO 2016, 2016/10, Without Invitation
  50. Japanese experience 1, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation
  51. How to organize and support basic and translational research in transplantation, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation
  52. Players of clinical tolerance: Tregs, Bregs, Macrophages, and others, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation
  53. Comparison of anti-donor immune response in recipients after kidney and pancreas-kidney transplantation, Kohei Ishiyama,Nobuki Ishida, Kentaro Ide, Yuka Tanaka, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation
  54. The Significant Association Between FOXP3 Gene Polymorphism and Severity of Acute Cellular Rejection in Liver Transplantation., Yuka Tanaka,Sapana Verma, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation
  55. Corticosteroids dampen Natural Killer cell function including cytotoxicity and anti-HCV effect, Masahiro Ohira,Ryuichi Hotta, Takuya Yano, Ryosuke Nakano, Andreas Tzakis, Seigo Nishida, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation
  56. Overexpression of PCDHB9 is associated with poor prognosis in gastric cancer, 2016/10, Without Invitation
  57. Current status of desensitization protocol for highly HLA-sensitized kidney transplant candidates, Kentaro Ide Hiroyuki Tahara, Asuka Tanaka, Shuji Akimoto, Sapana Verma, Lalit Kumar Das, Seiichi Shimizu, Masahiro Ohira, Kohei Ishiyama, Yuka Tanaka, Hideki Ohdan, 第50回日本臨床腎移植学会, 2017/02, Without Invitation
  58. Neo-adjuvant chemotherapy with G-SOX therapy for locally advanced gastric cancer., 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation
  59. The future perspective of conversion surgery for gastric cancer with liver metastasis, 89th Annual Meeting of The Japanese Gastric Cancer Association, 2017/03, Without Invitation
  60. IQGAP3 is involved in spheroid formation of gastric cancer cells, Yuji Yamamoto, Naohide Oue, Takeharu Imai, Kazuaki Tanabe, Hideki Ohdan, Naoya Sakamoto, Kazuhiro Sentani, Kazuhiro Yoshida, Wataru Yasui, 第89回日本胃癌学会, 2017/03, Without Invitation
  61. IQGAP3 is involved in spheroid formation of gastric cancer cells, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation
  62. Transmembrane protein BST2 is associated with poor survival in patients with gastric cancer, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation
  63. Overexpression of KIFC1 is associated with gastric spheroid formation, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation
  64. Adoptive Immunotherapy with Liver Allograft-Derived Lymphocytes Compensate for the Susceptibility to Post-LiverTransplant Blood Stream Infection Associated with FCGR3A SNP, Hideki Ohdan, 2017 American Transplant Congress, 2017/05/01, Without Invitation, American Transplant Congress, Chicago, Illinois
  65. Don't change your winning Formula!, 2017/05/20, With Invitation
  66. A PHASED DESENSITIZATION WITH RITUXIMAB AND BORTEZOMIB FOR HIGHLY SENSITIZED KIDNEY TRANSPLANT CANDIDATES., Hideki Ohdan, Kentaro Ide, Yuka Tanaka., 15th Transplantation Science Symposium (TSS2017), 2017/05/24, Without Invitation, 15th Transplantation Science Symposium (TSS2017), Victoria, BC, Canada
  67. Impact of donor-specific antibodies in liver transplantation, Hideki Ohdan, the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association(A-PHPBA2017) and the 29th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS29), 2017/06/10, With Invitation, the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association(A-PHPBA2017) and the 29th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS29)
  68. Practical ways to futher improve outcome of liver transplantation for HCC meeting Milan Criteria, Hideki Ohdan, the 53rd Annual Meeting of Liver Cancer Study Group of Japan, 2017/07/06, With Invitation, the 53rd Annual Meeting of Liver Cancer Study Group of Japan
  69. Impact of Immunoregulatory gene polymorphism in ABO-incompatible liver transplantation, Hideki Ohdan, Asian Transplantation Week 2017, 2017/10/20, With Invitation, Asian Transplantation Week 2017, Incheon

Awards

  1. 2010年10月, CHUGAI Award, ドナー肝由来リンパ球を用いた肝移植後肝癌・C型肝炎再発予防免疫療法の臨床評価
  2. 2011年06月11日, International TTS-JST Basic Science Mentee/Mentor Travel Award, XII The Transplantation Society Basic Science Symposium Chair Anita Chong, MD
  3. 2015年11月17日, DP(Distinguished Professor), Hiroshima University
  4. 2015年12月07日, Honorable Mention International Conference on Advanced Mechatronics (ICAM) 2015, ICAM2015 General Chair

Patented

  1. Patent, 5696317, 2015/02/20
  2. Patent, 5757483, 2015/06/12
  3. Patent, 6032669, 2016/11/04
  4. Patent, 6067330, 2017/01/06

External Funds

Acceptance Results of Competitive Funds

  1. Program on ICT Infrastructure Development for Clinical Research, 2017/04/01, 2018/03/31
  2. Research Program on Hepatitis , 2017/04/01, 2018/03/31
  3. Research Program on Hepatitis , 2017/04/01, 2018/03/31
  4. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2017/04/01, 2018/03/31
  5. Program on ICT Infrastructure Development for Clinical Research, 2016/10/17, 2017/03/31
  6. Research Program on Hepatitis , 2016/04/01, 2017/03/31
  7. Research Program on Hepatitis , 2016/04/01, 2017/03/31
  8. Research Program on Hepatitis , 2016/04/01, 2017/03/31
  9. Research Program on Hepatitis, 2015/04/01, 2016/03/31
  10. Research Program on Hepatitis, 2015/04/01, 2016/03/31
  11. Research Program on Hepatitis, 2015/04/01, 2016/03/31
  12. 2015/04/01, 2016/03/31
  13. KAKENHI, 2015, 2016
  14. KAKENHI, 2015, 2017
  15. KAKENHI, 2015, 2018
  16. 2015, 2015
  17. Health and Labour Sciences Research Grants, 2014/04/01, 2015/03/31
  18. 2014/03/01, 2017/03/31
  19. Health and Labour Sciences Research Grants, 2013/04/01, 2014/03/31
  20. KAKENHI, 2013, 2014
  21. KAKENHI, 2012, 2014
  22. 2011
  23. 2011
  24. 2011
  25. KAKENHI, Establishment of strategies to regulate antibody-mediated rejection on the basis of B cell differentiation biology, 2011, 2012
  26. KAKENHI, The CD47-SIRPa signaling blockade accelerates macrophage phagocytic activity against cancer cells, 2011, 2013
  27. 2010
  28. KAKENHI, The new strategy of NK cell therapy with death receptors for the patients with chollangiocellular carcinoma or mixed liver cancer, 2010, 2012
  29. 2009
  30. 2009
  31. KAKENHI, 2009, 2010
  32. KAKENHI, Inhibition of xeno-antigen reactive T cells and B cells by regulation of CD47-SIRP signaling, 2008, 2010
  33. KAKENHI, GalT-knockout pig to monkey xenogeneic kidney and islet transplantation, 2007, 2010
  34. KAKENHI, 2007, 2008
  35. KAKENHI, Regulation of innate and adaptive immune responses in xenotransplantation by modulating CD47sirp alpha signaling, 2006, 2007
  36. KAKENHI, Elucidation of the mechanism on carbohydrate antigen recognition by B cells through CD1d mediated signaling and establishment of a method to regulate B cells responding to the carbohydrate antigens in ABO-incompatible transplantation and xe, 2006, 2007
  37. KAKENHI, 2006, 2007
  38. KAKENHI, 2005, 2006
  39. KAKENHI, 2005, 2006
  40. KAKENHI, 2005, 2006
  41. KAKENHI, Elucidation of mechanisms for macrophage-mediated xenograft refection and a novel approach to prevent macrophage-mediated xenograft rejection by gene introduction of human CD47 to xenogenic cells, 2004, 2005
  42. KAKENHI, Development of synthetic immunotoxin that can enable ABC incompatible transplantation and xenotransplantation., 2004, 2005

Social Activities

Organizing Academic Conferences, etc.

  1. 2011/12
  2. 2012/02
  3. 2012/05
  4. 2013/08
  5. 2014/06, 2014/06
  6. 2014/09, 2014/09
  7. 2015/03, 2015/03
  8. 2015/09, 2015/09
  9. 2016/03, 2016/03
  10. 89th Annual Meeting of the Japanese Gastric Cancer Association, 2016/03, 2016/03
  11. 2016/09, 2016/09
  12. 2016/09, 2016/09
  13. 2017/06, 2017/06
  14. the 55th Annual Congress of The Japan Soceity for Transplantation, 2019/10, 2019/10
  15. 2017/09, 2017/09

History as Peer Reviews of Academic Papers

  1. 2010, Surgery Today
  2. 2011, Surgery Today
  3. 2012, Surgery Today
  4. 2012, Hepatology Research
  5. 2013, Surgery Today
  6. 2013, Hepatology Research
  7. 2014, Surgery Today
  8. 2014, Hepatology Research
  9. 2014, Transplant International, Associate Editor, 24
  10. 2014, Surgical case reports, Associate Editor, 24
  11. 2015, Hepatrology Research, associate editor
  12. 2015, Surgical case reports, associate editor
  13. 2015, Transplant International, associate editor
  14. 2016, Hiroshima Journal of Medical Science, 0
  15. 2016, Transplant International, associate editor
  16. 2016, Surgical case reports, associate editor
  17. 2016, Hepatology Research, associate editor
  18. 2017, Hepatology Research, Associate Editor